NCT03774043

Brief Summary

This study will utilize short duration and mild levels of reduced oxygen (hypoxia) to induce spinal plasticity while evaluating the appropriate timing schedule for this intervention, as well as, the effects of superimposing sessions of a therapy, in individuals with chronic incomplete SCI. Our aim is to establish the time-course of outcome improvement and decay following a single session or multiple sessions of AIH therapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started May 2016

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

December 11, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 12, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

February 19, 2020

Status Verified

February 1, 2020

Enrollment Period

3.8 years

First QC Date

December 11, 2018

Last Update Submit

February 17, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in grip strength

    A dynamometer measures maximum gross grasp (kglb) averaged over three attempts with each hand. The minimum possible value of zero kg lb will be assigned when the participant cannot actively flex the fingers or grasp the dynamometer. Standard position includes the participant in a supported sitting position, with shoulder in adducted and in neutral rotation and the elbow flexed at 90 degrees. The forearm should be in neutral rotation. The arm should not be supported by an arm rest or research personnel.

    Baseline, immediately following intervention, and every 30 minutes for 5 hours

  • Pinch Strength

    A pinch gauge measures maximum pinch force (kglb) averaged over three attempts with each hand. The minimum possible value of zero kg will be assigned when the participant cannot actively squeeze the pinch meter between the thumb and index finger. Standard position includes the participant in a supported sitting position, with shoulder in adducted and in neutral rotation and the elbow flexed at 90 degrees. The gauge will be placed between the thumb and lateral surface of the index finger (lateral pinch).

    Baseline, immediately following intervention, and every 30 minutes for 5 hours

  • 9 Hole Peg Test

    A measure of finger dexterity involving the placement of pegs from a container to holes on a board, and subsequent removal, as quickly as possible. The total number of seconds until task completion is recorded, as measured by when the participant touches the first peg to when the last peg is placed back into the container.

    Baseline, immediately following intervention, and every 30 minutes for 5 hours

  • Box and Blocks test

    A measure of manual dexterity that requires repeatedly moving 1-inch blocks from one side of a box to another in 60 seconds

    Baseline, immediately following intervention, and every 30 minutes for 5 hours

Study Arms (4)

Single session of Acute Intermittent Hypoxia (AIH)

EXPERIMENTAL
Other: Acute Intermittent Hypoxia

Single session of Sham Acute Intermittent Hypoxia (Sham AIH)

PLACEBO COMPARATOR
Other: Sham Acute Intermittent Hypoxia

Two successive sessions of AIH

EXPERIMENTAL
Other: Acute Intermittent Hypoxia

Two successive sessions of Sham AIH

PLACEBO COMPARATOR
Other: Sham Acute Intermittent Hypoxia

Interventions

Patients will breath 9%-11% oxigen for 1.5 minutes interspersed with 1.5 minutes of 21% oxigen (normoxia), 15 times for a total of 45 minutes.

Single session of Acute Intermittent Hypoxia (AIH)Two successive sessions of AIH

Patients will breath 21% oxigen for 1.5 minutes interspersed with 1.5 minutes of room air, 15 times for a total of 45 minutes.

Single session of Sham Acute Intermittent Hypoxia (Sham AIH)Two successive sessions of Sham AIH

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Spinal cord lesion at level of C3 to T1
  • Individuals with a history of incomplete spinal cord injury, classified as ASIA C or D
  • Individuals must be at least 6 months status post injury
  • Individuals must be between the ages of 18-70 years inclusive, male or female
  • Spinal cord injury must be secondary to a non-progressive etiology
  • Individuals must be medically stable.
  • Able to comply with protocol/study requirements
  • Not currently (\>2 weeks) taking any medications for spasticity management.

You may not qualify if:

  • Recent change in the use of narcotic, anti-inflammatory or pain medication
  • Unstable medical conditions or any other clinical observation that may affect the candidate's performance, health, safety or the ability to participate in the study, as determined by the treating therapist
  • History of sleep apnea
  • Active participation in another movement research study or therapy program
  • Anti-spasticity drug injection less than 3 months, prior to beginning treatment
  • Musculoskeletal pain that interferes with participation in study
  • Women who are currently, may be or planning on becoming pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Institute of Chicago

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Central Study Contacts

Milap Sandhu, PT, PhD

CONTACT

Sofia Anastasopoulos

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 11, 2018

First Posted

December 12, 2018

Study Start

May 1, 2016

Primary Completion

March 1, 2020

Study Completion

July 1, 2020

Last Updated

February 19, 2020

Record last verified: 2020-02

Locations